For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Pulmocide Ltd., (“the Company”), a late-stage biopharmaceutical company developing inhaled opelconazole for patients suffering from serious acute and chronic respiratory diseases, today announced that ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

No longer reserved for time solely at the gym, the best activewear brands often blend the lines between fashion and function, offering longevity outside of just a sweaty workout. If you need more ...

This exists but is only used for children. Your patient likes the sound of MART and wonders if she can keep using her current inhaler for this type of regime – her current brand is Seretide. Which of ...

A teenager who inhaled laughing gas at the wheel before losing control of his BMW and crashing into a tree has been jailed for nine years for killing his three friends. Thomas Johnson, 19 ...

COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled human insulin (Afrezza Inhalation Powder).